Nabumetone

Overview

Nabumetone is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions like arthritis. It is a prodrug that is metabolized in the liver to its active form, 6-methoxy-2-naphthylacetic acid (6MNA).

API suppliers (15)

Suppliers of Nabumetone evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• SOUTHWEST SYNTHETIC PHARMACEUTICAL CORP LTDChina1 active DMF
• ERREGIERRE SPAItaly1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• Hetero Drugs LimitedIndia1 active DMF GMP on record
• Divis LaboratoriesIndia1 active DMF GMP on record
• Ipca Laboratories LimitedIndia GMP on record
• JIANGSU ZHONGDAN PHARMACEUTICAL CO LTD
• ESTEVE QUIMICA SA GMP on record
• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly GMP on record
• DINAMITE DIPHARMA SPA
• CHEMI SPAItaly GMP on record
• NAPP TECHNOLOGIES INCUnited States
• PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
• RecordatiItaly GMP on record

EU CEP holders (2)

Companies holding a valid EU Certificate of Suitability (CEP) for Nabumetone, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas